| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 3.95e-05 | 188 | 173 | 9 | GO:0005201 | |
| GeneOntologyMolecularFunction | latrotoxin receptor activity | 7.46e-05 | 2 | 173 | 2 | GO:0016524 | |
| GeneOntologyMolecularFunction | epidermal growth factor receptor activity | 4.43e-04 | 4 | 173 | 2 | GO:0005006 | |
| GeneOntologyMolecularFunction | cytokine binding | 4.45e-04 | 157 | 173 | 7 | GO:0019955 | |
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | 4.78e-04 | 114 | 173 | 6 | GO:0004843 | |
| GeneOntologyMolecularFunction | C-X3-C chemokine binding | 7.34e-04 | 5 | 173 | 2 | GO:0019960 | |
| GeneOntologyMolecularFunction | collagen binding involved in cell-matrix adhesion | 7.34e-04 | 5 | 173 | 2 | GO:0098639 | |
| GeneOntologyMolecularFunction | deubiquitinase activity | 7.45e-04 | 124 | 173 | 6 | GO:0101005 | |
| GeneOntologyMolecularFunction | death receptor activity | 7.58e-04 | 21 | 173 | 3 | GO:0005035 | |
| GeneOntologyCellularComponent | extracellular matrix | THSD4 ADAMTSL1 COL6A6 TFPI2 ITGB1 EFEMP1 MEGF9 ADAMTS7 SPOCK3 LTBP2 LTBP3 LGR6 BMPER ADAMTS14 MUC5AC MUC6 CDH13 | 4.14e-05 | 656 | 176 | 17 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | THSD4 ADAMTSL1 COL6A6 TFPI2 ITGB1 EFEMP1 MEGF9 ADAMTS7 SPOCK3 LTBP2 LTBP3 LGR6 BMPER ADAMTS14 MUC5AC MUC6 CDH13 | 4.30e-05 | 658 | 176 | 17 | GO:0030312 |
| GeneOntologyCellularComponent | integrin alpha10-beta1 complex | 7.05e-05 | 2 | 176 | 2 | GO:0034680 | |
| GeneOntologyCellularComponent | cerebellar climbing fiber to Purkinje cell synapse | 9.21e-05 | 11 | 176 | 3 | GO:0150053 | |
| GeneOntologyCellularComponent | integrin alpha9-beta1 complex | 2.10e-04 | 3 | 176 | 2 | GO:0034679 | |
| GeneOntologyCellularComponent | tumor necrosis factor receptor superfamily complex | 4.18e-04 | 4 | 176 | 2 | GO:0002947 | |
| GeneOntologyCellularComponent | receptor complex | IL13RA1 ERBB4 GFRAL ITGA10 GRIK3 ITGB1 LRP1B ITGB3 TRBV29-1 PIGR PLXNC1 TNFRSF1A TNFRSF1B TRAV22 | 4.20e-04 | 581 | 176 | 14 | GO:0043235 |
| GeneOntologyCellularComponent | external side of plasma membrane | SIGLEC12 IL13RA1 GFRAL CD244 CCR9 ITGA10 ADAM29 ITGB1 ITGB3 MICB SCART1 CDH13 GP2 | 4.70e-04 | 519 | 176 | 13 | GO:0009897 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | CABP7 INHBA ARFGEF2 ITGB1 USP20 RYR1 TG PACS1 IGF2R SYNJ1 CCDC78 ATXN10 HSP90AB2P TNFRSF1B TNKS2 CDH13 HERC5 USP33 | 9.31e-04 | 934 | 176 | 18 | GO:0048471 |
| GeneOntologyCellularComponent | asymmetric, glutamatergic, excitatory synapse | 1.04e-03 | 24 | 176 | 3 | GO:0098985 | |
| Domain | GPS | 6.72e-07 | 34 | 175 | 6 | SM00303 | |
| Domain | RCC1 | 9.44e-07 | 20 | 175 | 5 | PF00415 | |
| Domain | GPS | 1.13e-06 | 37 | 175 | 6 | IPR000203 | |
| Domain | RCC1_1 | 1.23e-06 | 21 | 175 | 5 | PS00625 | |
| Domain | RCC1_2 | 1.23e-06 | 21 | 175 | 5 | PS00626 | |
| Domain | RCC1_3 | 1.23e-06 | 21 | 175 | 5 | PS50012 | |
| Domain | - | 1.58e-06 | 22 | 175 | 5 | 2.130.10.30 | |
| Domain | Reg_chr_condens | 1.58e-06 | 22 | 175 | 5 | IPR000408 | |
| Domain | TSP_1 | 2.00e-06 | 63 | 175 | 7 | PF00090 | |
| Domain | RCC1/BLIP-II | 2.00e-06 | 23 | 175 | 5 | IPR009091 | |
| Domain | TSP1 | 2.48e-06 | 65 | 175 | 7 | SM00209 | |
| Domain | TSP1_rpt | 2.48e-06 | 65 | 175 | 7 | IPR000884 | |
| Domain | TSP1 | 2.48e-06 | 65 | 175 | 7 | PS50092 | |
| Domain | GPS | 1.76e-05 | 35 | 175 | 5 | PF01825 | |
| Domain | GPS | 2.03e-05 | 36 | 175 | 5 | PS50221 | |
| Domain | PLAC | 2.59e-05 | 19 | 175 | 4 | PS50900 | |
| Domain | PLAC | 2.59e-05 | 19 | 175 | 4 | IPR010909 | |
| Domain | Ribosomal_S27e | 8.73e-05 | 2 | 175 | 2 | IPR000592 | |
| Domain | Ribosomal_S27e_Zn-bd_dom | 8.73e-05 | 2 | 175 | 2 | IPR023407 | |
| Domain | ASH | 8.73e-05 | 2 | 175 | 2 | IPR031549 | |
| Domain | Ribosomal_S27e | 8.73e-05 | 2 | 175 | 2 | PD004466 | |
| Domain | RIBOSOMAL_S27E | 8.73e-05 | 2 | 175 | 2 | PS01168 | |
| Domain | Ribosomal_S27e | 8.73e-05 | 2 | 175 | 2 | PF01667 | |
| Domain | ASH | 8.73e-05 | 2 | 175 | 2 | PF15780 | |
| Domain | - | 8.73e-05 | 2 | 175 | 2 | 2.20.25.100 | |
| Domain | TNFR | 9.48e-05 | 26 | 175 | 4 | SM00208 | |
| Domain | 7tm_2 | 1.03e-04 | 50 | 175 | 5 | PF00002 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 1.03e-04 | 50 | 175 | 5 | PS00650 | |
| Domain | GAIN_dom_N | 1.26e-04 | 11 | 175 | 3 | IPR032471 | |
| Domain | GAIN | 1.26e-04 | 11 | 175 | 3 | PF16489 | |
| Domain | C8 | 1.67e-04 | 12 | 175 | 3 | PF08742 | |
| Domain | TIL | 1.67e-04 | 12 | 175 | 3 | PF01826 | |
| Domain | RA | 1.92e-04 | 31 | 175 | 4 | SM00314 | |
| Domain | Unchr_dom_Cys-rich | 2.16e-04 | 13 | 175 | 3 | IPR014853 | |
| Domain | C8 | 2.16e-04 | 13 | 175 | 3 | SM00832 | |
| Domain | ARM-like | 2.38e-04 | 270 | 175 | 10 | IPR011989 | |
| Domain | GPCR_2_secretin-like | 2.46e-04 | 60 | 175 | 5 | IPR000832 | |
| Domain | GPCR_2-like | 2.46e-04 | 60 | 175 | 5 | IPR017981 | |
| Domain | TNFR/NGFR_Cys_rich_reg | 2.46e-04 | 33 | 175 | 4 | IPR001368 | |
| Domain | Latrophilin | 2.60e-04 | 3 | 175 | 2 | PF02354 | |
| Domain | GPCR_2_latrophilin_rcpt_C | 2.60e-04 | 3 | 175 | 2 | IPR003334 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 2.65e-04 | 61 | 175 | 5 | PS50261 | |
| Domain | TIL_dom | 2.73e-04 | 14 | 175 | 3 | IPR002919 | |
| Domain | RA | 3.47e-04 | 36 | 175 | 4 | PF00788 | |
| Domain | RA | 3.86e-04 | 37 | 175 | 4 | PS50200 | |
| Domain | VWF_type-D | 4.14e-04 | 16 | 175 | 3 | IPR001846 | |
| Domain | VWFD | 4.14e-04 | 16 | 175 | 3 | PS51233 | |
| Domain | VWD | 4.14e-04 | 16 | 175 | 3 | SM00216 | |
| Domain | VWD | 4.14e-04 | 16 | 175 | 3 | PF00094 | |
| Domain | - | 4.99e-04 | 17 | 175 | 3 | 4.10.800.10 | |
| Domain | Thyroglobulin_1 | 4.99e-04 | 17 | 175 | 3 | IPR000716 | |
| Domain | THYROGLOBULIN_1_1 | 4.99e-04 | 17 | 175 | 3 | PS00484 | |
| Domain | TY | 4.99e-04 | 17 | 175 | 3 | SM00211 | |
| Domain | THYROGLOBULIN_1_2 | 4.99e-04 | 17 | 175 | 3 | PS51162 | |
| Domain | Thyroglobulin_1 | 4.99e-04 | 17 | 175 | 3 | PF00086 | |
| Domain | - | 5.17e-04 | 4 | 175 | 2 | 1.20.5.630 | |
| Domain | N-RASSF | 5.17e-04 | 4 | 175 | 2 | IPR033593 | |
| Domain | GPCR_2_extracellular_dom | 5.23e-04 | 40 | 175 | 4 | IPR001879 | |
| Domain | RA_dom | 5.23e-04 | 40 | 175 | 4 | IPR000159 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 5.23e-04 | 40 | 175 | 4 | PS00649 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 5.23e-04 | 40 | 175 | 4 | PS50227 | |
| Domain | EGF_1 | 6.90e-04 | 255 | 175 | 9 | PS00022 | |
| Domain | PSI | 7.55e-04 | 44 | 175 | 4 | IPR016201 | |
| Domain | EGF-like_CS | 8.14e-04 | 261 | 175 | 9 | IPR013032 | |
| Domain | Gal_Lectin | 8.57e-04 | 5 | 175 | 2 | PF02140 | |
| Domain | GPCR_2_latrophilin | 8.57e-04 | 5 | 175 | 2 | IPR003924 | |
| Domain | Lectin_gal-bd_dom | 8.57e-04 | 5 | 175 | 2 | IPR000922 | |
| Domain | SUEL_LECTIN | 8.57e-04 | 5 | 175 | 2 | PS50228 | |
| Domain | PSI | 8.94e-04 | 46 | 175 | 4 | SM00423 | |
| Domain | VWFA | 1.04e-03 | 82 | 175 | 5 | PS50234 | |
| Domain | TNFR_c6 | 1.09e-03 | 22 | 175 | 3 | PF00020 | |
| Domain | VWA | 1.16e-03 | 84 | 175 | 5 | SM00327 | |
| Domain | - | 1.19e-03 | 222 | 175 | 8 | 1.25.10.10 | |
| Domain | ADAM_spacer1 | 1.25e-03 | 23 | 175 | 3 | IPR010294 | |
| Domain | ADAM_spacer1 | 1.25e-03 | 23 | 175 | 3 | PF05986 | |
| Domain | DUSP | 1.28e-03 | 6 | 175 | 2 | PF06337 | |
| Domain | Integrin_b_cyt | 1.28e-03 | 6 | 175 | 2 | SM01241 | |
| Domain | Integrin_b_cyt | 1.28e-03 | 6 | 175 | 2 | PF08725 | |
| Domain | DUSP | 1.28e-03 | 6 | 175 | 2 | SM00695 | |
| Domain | Integrin_bsu_cyt_dom | 1.28e-03 | 6 | 175 | 2 | IPR014836 | |
| Domain | ARM-type_fold | RTTN ARFGEF2 HEATR5A USP9Y ASPM ZER1 ATXN10 PRKDC NUP188 XPOT | 1.39e-03 | 339 | 175 | 10 | IPR016024 |
| Domain | Peptidase_M12B_ADAM-TS | 1.42e-03 | 24 | 175 | 3 | IPR013273 | |
| Domain | Integrin_dom | 1.60e-03 | 25 | 175 | 3 | IPR032695 | |
| Domain | HormR | 1.60e-03 | 25 | 175 | 3 | SM00008 | |
| Domain | TB | 1.78e-03 | 7 | 175 | 2 | PF00683 | |
| Domain | DUSP | 1.78e-03 | 7 | 175 | 2 | PS51283 | |
| Domain | Integrin_B_tail | 1.78e-03 | 7 | 175 | 2 | SM01242 | |
| Domain | Integrin_bsu_tail | 1.78e-03 | 7 | 175 | 2 | IPR012896 | |
| Domain | - | 1.78e-03 | 7 | 175 | 2 | 3.30.2230.10 | |
| Domain | CBM21_dom | 1.78e-03 | 7 | 175 | 2 | IPR005036 | |
| Domain | CBM21 | 1.78e-03 | 7 | 175 | 2 | PS51159 | |
| Domain | Pept_C19_DUSP | 1.78e-03 | 7 | 175 | 2 | IPR006615 | |
| Domain | Integrin_B_tail | 1.78e-03 | 7 | 175 | 2 | PF07965 | |
| Domain | CBM_21 | 1.78e-03 | 7 | 175 | 2 | PF03370 | |
| Domain | cEGF | 1.79e-03 | 26 | 175 | 3 | PF12662 | |
| Domain | cEGF | 1.79e-03 | 26 | 175 | 3 | IPR026823 | |
| Domain | HRM | 2.23e-03 | 28 | 175 | 3 | PF02793 | |
| Domain | - | 2.36e-03 | 8 | 175 | 2 | 3.90.290.10 | |
| Domain | INB | 2.36e-03 | 8 | 175 | 2 | SM00187 | |
| Domain | Integrin_bsu_VWA | 2.36e-03 | 8 | 175 | 2 | IPR002369 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 3.28e-07 | 68 | 139 | 8 | M27303 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.06e-06 | 39 | 139 | 6 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.06e-06 | 39 | 139 | 6 | MM15165 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.20e-05 | 109 | 139 | 8 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.37e-05 | 111 | 139 | 8 | M27416 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 2.93e-05 | 37 | 139 | 5 | M27134 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 6.91e-05 | 44 | 139 | 5 | M26969 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 8.48e-05 | 143 | 139 | 8 | M27275 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 9.54e-05 | 47 | 139 | 5 | M646 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | THSD4 ADAMTSL1 THSD7A SEMA5A PPP1R3C ADAMTS7 ADAMTS14 PC MUC5AC MUC6 | 1.85e-04 | 250 | 139 | 10 | M27554 |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 2.63e-04 | 32 | 139 | 4 | MM14854 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FLII RTTN OBSCN ARFGEF2 ADGRL1 CLDN3 RASSF7 RYR1 IGF2R SYNJ1 ADAMTS7 ZNF592 ZMIZ2 BANP HELZ2 ZER1 LTBP3 PRKDC NUP188 TNFAIP3 HERC1 PC ARHGAP21 TOP3A | 3.40e-09 | 1105 | 180 | 24 | 35748872 |
| Pubmed | FLII KRT83 ADGRB3 ARFGEF2 AIRE USP9Y LRP1B EEF2 UBE2O EFEMP1 ZNF660 SYNJ1 MEGF9 ZNF592 RCBTB1 MIB1 LTBP3 ATXN10 PRKDC TNKS2 PC ARHGAP21 USP33 XPOT | 5.94e-08 | 1285 | 180 | 24 | 35914814 | |
| Pubmed | 1.31e-07 | 75 | 180 | 7 | 20637190 | ||
| Pubmed | International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors. | 7.41e-07 | 33 | 180 | 5 | 25713288 | |
| Pubmed | 1.35e-06 | 5 | 180 | 3 | 9144497 | ||
| Pubmed | 1.35e-06 | 5 | 180 | 3 | 12133972 | ||
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | CCR9 OBSCN ARFGEF2 RPS27L CDC45 YEATS2 EEF2 IGF2R ATXN10 PRKDC NUP188 ALDH1A3 MUC5AC XPOT | 1.62e-06 | 564 | 180 | 14 | 21565611 |
| Pubmed | NOTCH inhibits osteoblast formation in inflammatory arthritis via noncanonical NF-κB. | 2.70e-06 | 6 | 180 | 3 | 24892805 | |
| Pubmed | 2.70e-06 | 6 | 180 | 3 | 16294221 | ||
| Pubmed | Production of IFN-gamma by CD4 T cells is essential for resolving ehrlichia infection. | 1.12e-05 | 9 | 180 | 3 | 15153508 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ERBB4 SETX ALS2 RPS27 STIL RASSF7 FSIP2 SYNJ1 IKBKE SYNE2 TNFAIP3 CGNL1 RASSF8 KIF13A PC ARHGAP21 | 1.16e-05 | 861 | 180 | 16 | 36931259 |
| Pubmed | The human and mouse repertoire of the adhesion family of G-protein-coupled receptors. | 1.49e-05 | 29 | 180 | 4 | 15203201 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 1.49e-05 | 101 | 180 | 6 | 23382219 | |
| Pubmed | 1.59e-05 | 10 | 180 | 3 | 21768400 | ||
| Pubmed | 2.07e-05 | 107 | 180 | 6 | 28005267 | ||
| Pubmed | 2.53e-05 | 33 | 180 | 4 | 24159190 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 1849278 | ||
| Pubmed | The p55 TNF-alpha receptor plays a critical role in T cell alloreactivity. | 2.66e-05 | 2 | 180 | 2 | 10623807 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 9551964 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 10779546 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 16732051 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 12786601 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 30793619 | ||
| Pubmed | Modulation of allergic inflammation in mice deficient in TNF receptors. | 2.66e-05 | 2 | 180 | 2 | 11076794 | |
| Pubmed | TNFalpha transport across the blood-brain barrier is abolished in receptor knockout mice. | 2.66e-05 | 2 | 180 | 2 | 11922661 | |
| Pubmed | Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. | 2.66e-05 | 2 | 180 | 2 | 10500078 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 11861282 | ||
| Pubmed | Dendritic cell maturation and survival are differentially regulated by TNFR1 and TNFR2. | 2.66e-05 | 2 | 180 | 2 | 25288570 | |
| Pubmed | Sources of alveolar soluble TNF receptors during acute lung injury of different etiologies. | 2.66e-05 | 2 | 180 | 2 | 21512145 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 25034210 | ||
| Pubmed | Soluble TNFRp75 regulates host protective immunity against Mycobacterium tuberculosis. | 2.66e-05 | 2 | 180 | 2 | 24569452 | |
| Pubmed | Role of the tumor necrosis factor receptor 2 (TNFR2) in cerebral malaria in mice. | 2.66e-05 | 2 | 180 | 2 | 12218076 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 33270628 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 10225939 | ||
| Pubmed | Mechanisms of sex differences in TNFR2-mediated cardioprotection. | 2.66e-05 | 2 | 180 | 2 | 18824767 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 17573778 | ||
| Pubmed | β3 integrin is dispensable for conditioned fear and hebbian forms of plasticity in the hippocampus. | 2.66e-05 | 2 | 180 | 2 | 22748100 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 16277675 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 18248655 | ||
| Pubmed | TNFR1 and TNFR2 regulate the extrinsic apoptotic pathway in myeloma cells by multiple mechanisms. | 2.66e-05 | 2 | 180 | 2 | 21850048 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 25552370 | ||
| Pubmed | Circulating TNF receptors predict cardiovascular disease in patients with chronic kidney disease. | 2.66e-05 | 2 | 180 | 2 | 28489742 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 32779270 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 19766701 | ||
| Pubmed | Distinct contributions of TNF receptor 1 and 2 to TNF-induced glomerular inflammation in mice. | 2.66e-05 | 2 | 180 | 2 | 23869211 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 18510047 | ||
| Pubmed | Potential Role of Soluble TNF-α Receptors in Diagnosis of Patients with Chronic Kidney Disease. | 2.66e-05 | 2 | 180 | 2 | 28667032 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 25783894 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 7990930 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 24378531 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 23389459 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 21836066 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 28815559 | ||
| Pubmed | Hyper innate responses in neonates lead to increased morbidity and mortality after infection. | 2.66e-05 | 2 | 180 | 2 | 18490660 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 25098821 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 28321513 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 15047807 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 8910423 | ||
| Pubmed | Tumor necrosis factor-alpha receptor p75 is required in ischemia-induced neovascularization. | 2.66e-05 | 2 | 180 | 2 | 17261656 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 21378027 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 15698630 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 22547679 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 34234786 | ||
| Pubmed | A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. | 2.66e-05 | 2 | 180 | 2 | 10875917 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 36012570 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 24473438 | ||
| Pubmed | Role of TNF-{alpha} signaling in regeneration of cardiotoxin-injured muscle. | 2.66e-05 | 2 | 180 | 2 | 16079187 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 22982304 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 11245629 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 22972916 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 22511753 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 18415772 | ||
| Pubmed | Increased concentration of plasma TNFR1 and TNFR2 in paediatric lupus nephritis. | 2.66e-05 | 2 | 180 | 2 | 26854079 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 18488137 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 19477937 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 15841213 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 24748490 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 27188183 | ||
| Pubmed | Regulation of infection with Histoplasma capsulatum by TNFR1 and -2. | 2.66e-05 | 2 | 180 | 2 | 10946295 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 37612373 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 16081594 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 23316846 | ||
| Pubmed | The beta1 and beta3 integrins promote T cell receptor-mediated cytotoxic T lymphocyte activation. | 2.66e-05 | 2 | 180 | 2 | 12690105 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 38382266 | ||
| Pubmed | Exacerbated febrile responses to LPS, but not turpentine, in TNF double receptor-knockout mice. | 2.66e-05 | 2 | 180 | 2 | 9124479 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 11777546 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 10101016 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 12858434 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 25783484 | ||
| Pubmed | Urothelial lesion formation is mediated by TNFR1 during neurogenic cystitis. | 2.66e-05 | 2 | 180 | 2 | 16622179 | |
| Pubmed | Hypersensitivity of Vagal Pulmonary Afferents Induced by Tumor Necrosis Factor Alpha in Mice. | 2.66e-05 | 2 | 180 | 2 | 28659824 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 11740910 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 31618629 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 25842288 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 7595529 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 12054175 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 9485205 | ||
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 31906244 | ||
| Pubmed | DNA-PKcs interacts with Aire and regulates the expression of toll-like receptors in RAW264.7 cells. | 2.66e-05 | 2 | 180 | 2 | 22239103 | |
| Pubmed | 2.66e-05 | 2 | 180 | 2 | 22215119 | ||
| Interaction | ZNF563 interactions | 2.52e-06 | 12 | 174 | 4 | int:ZNF563 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | IL13RA1 CD244 CCR9 TNFRSF10B ITGB1 ITGB3 IGF2R PLXNC1 TNFRSF1A TNFRSF1B EPCAM | 1.22e-04 | 394 | 129 | 11 | 471 |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily L | 3.00e-04 | 4 | 129 | 2 | 918 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 3.00e-04 | 4 | 129 | 2 | 628 | |
| GeneFamily | Ubiquitin specific peptidases | 6.82e-04 | 56 | 129 | 4 | 366 | |
| GeneFamily | ADAMTS like | 1.04e-03 | 7 | 129 | 2 | 947 | |
| GeneFamily | CD molecules|Tumor necrosis factor receptor superfamily|Death inducing signaling complex | 1.13e-03 | 29 | 129 | 3 | 782 | |
| GeneFamily | CD molecules|Integrin beta subunits | 1.76e-03 | 9 | 129 | 2 | 1159 | |
| GeneFamily | Ras association domain family | 2.19e-03 | 10 | 129 | 2 | 1198 | |
| GeneFamily | UPF1 like RNA helicases | 2.66e-03 | 11 | 129 | 2 | 1169 | |
| GeneFamily | ATAC complex | 3.74e-03 | 13 | 129 | 2 | 1058 | |
| Coexpression | NABA_MATRISOME | THSD4 ADAMTSL1 SFRP4 COL6A6 INHBA C1QTNF9B SEMA5A ADAM29 INTS14 EFEMP1 MEGF9 ADAMTS7 PLXNC1 SPOCK3 C1QTNF9 LTBP2 LTBP3 BMPER ADAMTS14 MUC5AC MUC6 | 4.88e-06 | 1008 | 177 | 21 | MM17056 |
| Coexpression | NABA_MATRISOME | THSD4 ADAMTSL1 SFRP4 COL6A6 INHBA C1QTNF9B SEMA5A ADAM29 INTS14 EFEMP1 MEGF9 ADAMTS7 PLXNC1 SPOCK3 C1QTNF9 LTBP2 LTBP3 BMPER ADAMTS14 MUC5AC MUC6 | 6.40e-06 | 1026 | 177 | 21 | M5889 |
| Coexpression | BUSSLINGER_GASTRIC_PREZYMOGENIC_CELLS | 5.37e-05 | 60 | 177 | 5 | M40007 | |
| Coexpression | DESCARTES_FETAL_LIVER_MESOTHELIAL_CELLS | THSD4 ERBB4 FAHD2B INHBA TFPI2 SLITRK4 RASSF7 POF1B EFEMP1 RASSF8 | 5.67e-05 | 313 | 177 | 10 | M40228 |
| Coexpression | GSE21927_SPLEEN_VS_BONE_MARROW_MONOCYTE_BALBC_UP | 5.87e-05 | 196 | 177 | 8 | M7562 | |
| Coexpression | GSE22501_PERIPHERAL_BLOOD_VS_CORD_BLOOD_TREG_UP | 6.31e-05 | 198 | 177 | 8 | M8370 | |
| Coexpression | GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_GATA1_AND_SATB1_TRANSDUCED_CD4_TCELL_DN | 6.53e-05 | 199 | 177 | 8 | M9170 | |
| Coexpression | GSE26495_NAIVE_VS_PD1LOW_CD8_TCELL_DN | 6.77e-05 | 200 | 177 | 8 | M4659 | |
| Coexpression | GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_UP | 6.77e-05 | 200 | 177 | 8 | M8087 | |
| Coexpression | GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_48H_UP | 6.77e-05 | 200 | 177 | 8 | M6044 | |
| ToppCell | Calu_3|World / Cell line, Condition and Strain | INHBA ADGRG1 CLDN3 PARP14 RASSF7 SYNE2 HELZ2 ALDH1A3 EPCAM MUC5AC | 9.52e-09 | 200 | 180 | 10 | a549aa08aeefe905653266dae3936094ff55f8e4 |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.61e-08 | 177 | 180 | 9 | b59967219f7d874805768e247c0eb2bc4d4420c8 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3_VIP_CBLN1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.59e-08 | 181 | 180 | 9 | 7846c7b33d1b89364c5a704edaa86520db731c89 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.74e-08 | 188 | 180 | 9 | 3cfba3addcc9058f4ec31ad96261f79988f551a0 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | ADAMTSL1 THSD7A INHBA ITGA10 TNFRSF10B PARP14 SYNE2 CGNL1 BMPER | 9.68e-08 | 193 | 180 | 9 | 2531266bc57339d4e2b22a88817008e32b8c1598 |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.10e-07 | 196 | 180 | 9 | 3e99a367b7d817e1f1221450fcec20ad7a7c7a2a | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.10e-07 | 196 | 180 | 9 | 1efacc37bbfbd05b5d4db3dd10f6d9a238d23e31 | |
| ToppCell | Severe_COVID-19-Epithelial-transitional_Epi|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.15e-07 | 197 | 180 | 9 | 5ad3cd4c77016e862041baac3076f8cc0f75c417 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.15e-07 | 197 | 180 | 9 | 08b371309cd790b171ed76cabc7d910e71cd2835 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-transitional_Epi|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.15e-07 | 197 | 180 | 9 | 9f49feee38647bbf964974aac96fa75602186b5c | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | ADAMTSL1 SFRP4 INHBA ITGA10 GRIK3 ITGB3 PTPN5 LTBP3 ADAMTS14 | 1.26e-07 | 199 | 180 | 9 | fbec5c034576cb1adaf05f6f97cc5525d19e0c1b |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.26e-07 | 199 | 180 | 9 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.26e-07 | 199 | 180 | 9 | e03bdc7cb825e287f41b834ec6061d23c1c03b04 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CHRM2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.31e-07 | 200 | 180 | 9 | 501a3b93624df463458a35d3e6648d4ccc941724 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CHRM2-L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.31e-07 | 200 | 180 | 9 | d1f36a8232411933b1494168ec912fd0e5246428 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.34e-07 | 155 | 180 | 8 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.60e-07 | 164 | 180 | 8 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo-epi_neuroendocrine2[NE2]_(12)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.93e-07 | 182 | 180 | 8 | dc29e8735c3562ce32322351d28f7d9709208ebf | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.97e-07 | 185 | 180 | 8 | 0b5a0df58ae2ad8261f40f152775747af4f3937a | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.73e-07 | 187 | 180 | 8 | 9c1013720c248ef201d010806b6e7ad24205e8ee | |
| ToppCell | P07-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.01e-06 | 188 | 180 | 8 | 6ec22b79b19d57ea187f312907819dc2d01f3efe | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.05e-06 | 189 | 180 | 8 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-filiform|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-06 | 190 | 180 | 8 | 251e3a33041023bfc4b547c7eb68cfb8f421636f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.10e-06 | 190 | 180 | 8 | 938d1f66094b1c94606e0d40213a39e5112f3322 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.10e-06 | 190 | 180 | 8 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.14e-06 | 191 | 180 | 8 | 72dbd2e0fabfca8d6f604df35277d3574739a0b3 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.14e-06 | 191 | 180 | 8 | 05731ece7867659c662f952812805f947032fe10 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.19e-06 | 192 | 180 | 8 | 4e689bca7a242f8482e25f273656e2caba8821c0 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.19e-06 | 192 | 180 | 8 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_neuroendo|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.23e-06 | 193 | 180 | 8 | aa10924b203c71e65fdbd2b90ba131dbd362d8b1 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Basal_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.44e-06 | 197 | 180 | 8 | a4855c5aebea4f0fed4eb035844572e82e5bac46 | |
| ToppCell | Bronchial_Brush-Epithelial|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.44e-06 | 197 | 180 | 8 | 272c7f4e582ef57564450540242b0db766b78328 | |
| ToppCell | COVID-19-Epithelial|COVID-19 / Condition, Lineage and Cell class | 1.44e-06 | 197 | 180 | 8 | 18fd7344628a87d5c7ef5efb66e260a4136245bf | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.55e-06 | 199 | 180 | 8 | 7223f853335492ca617dbec3e4b6872a8a463a45 | |
| ToppCell | Caecum-T_cell-cycling_gd_T|T_cell / Region, Cell class and subclass | 1.55e-06 | 199 | 180 | 8 | 64d1e495307a91bc012130613126d86e0cf170b0 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-06 | 199 | 180 | 8 | 2e7f517c0444b4f29ff11c26ab32e9cc0f7e99ef | |
| ToppCell | (1)_T_cell-(18)_cycling_gd_T|(1)_T_cell / shred on Cell_type and subtype | 1.55e-06 | 199 | 180 | 8 | 9369d0e4efe809e3e8757294ebebba5a47b30528 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.61e-06 | 200 | 180 | 8 | c450a15e21fa72d071ed6e3b9f22de557a0f3cea | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CBLN1-L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.61e-06 | 200 | 180 | 8 | 2086024ce808b8796ed508a229b098eb02f8828a | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CBLN1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.61e-06 | 200 | 180 | 8 | 35951db6a4f442ac9e13f1b8cc5b4a33481f92c8 | |
| ToppCell | Kidney|World / Skin and Kidney Cells in Lupus Nephritis Patients. | 1.61e-06 | 200 | 180 | 8 | 1f99afa1f3c32a2a9cfb4ad33ff4d404e34fac63 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-06 | 200 | 180 | 8 | d9dab2aed11e45c60d11ff0c5af1f2fbb9cb45d8 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 1.61e-06 | 200 | 180 | 8 | f5bc7d30aa03dd0f95eb64255bd1a2543be8d327 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-06 | 200 | 180 | 8 | 33b7af6c50e65dc1bdf429572574ed072f8bc29f | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.61e-06 | 200 | 180 | 8 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.41e-06 | 162 | 180 | 7 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.18e-06 | 166 | 180 | 7 | 575c325db88d6909cdf0d5e664bd9098b89d4401 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.18e-06 | 166 | 180 | 7 | 000faacc79b0bd279ddce4e692d801e7e2063ab6 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.39e-06 | 167 | 180 | 7 | abc4ba308ca3be41b0da604f5d82579fd58dff7b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.39e-06 | 167 | 180 | 7 | 166b7b4ca0663cde6d88219ee0bcc1988d03dab8 | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-prox-progenitor-MUC5AC+ASCL1+_intermediate_|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.06e-06 | 170 | 180 | 7 | d6e244725b21592c6056b9c443aac090f1eae836 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Endocervical_Adenocarcinoma-Mucinous_Adenocarcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 6.30e-06 | 171 | 180 | 7 | 1af575809b3334bfaa019ff26c56e6cb03c82ee8 | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 6.54e-06 | 172 | 180 | 7 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.54e-06 | 172 | 180 | 7 | c84cab89c97d647b8a256fd08e33d9102810febd | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.79e-06 | 173 | 180 | 7 | 20889aa85e36ad3bafdb91b91e43964493c949f9 | |
| ToppCell | facs-GAT-Fat-24m-Epithelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.79e-06 | 173 | 180 | 7 | 98e464d9e6d6b69421e9e4041b638b6825247f60 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.79e-06 | 173 | 180 | 7 | 46e601b7938b1dd0aa3df7aa056c4bd07b1620c1 | |
| ToppCell | facs-GAT-Fat-24m-Epithelial-epithelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.79e-06 | 173 | 180 | 7 | 3e6f0a08eddfd61871f7a85acccf6d539af6ebda | |
| ToppCell | facs-GAT-Fat-24m-Epithelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.79e-06 | 173 | 180 | 7 | 815ba48a9222ea09ba8005e2d2f7c5addf118ad1 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.89e-06 | 177 | 180 | 7 | 5bccc7a74019eae8afd977a9c9134d884857ac27 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.18e-06 | 178 | 180 | 7 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.18e-06 | 178 | 180 | 7 | 49a2271718637522f74334068d252963ee13b1ce | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.18e-06 | 178 | 180 | 7 | 9a3ef66814dfca7b37024e7f79e86ea8c72ae10f | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.18e-06 | 178 | 180 | 7 | b413a634283550fa224db7d0d05956e3f64694a1 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-undefined_Epi|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.18e-06 | 178 | 180 | 7 | 19b5432aa1d7f616d58a106543c18cf2d7ca840c | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.80e-06 | 180 | 180 | 7 | ca7c316027e31559103b2cab1a2c0de993e42e95 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Hematopoietic-T_cells|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.80e-06 | 180 | 180 | 7 | eb26ba86fba26899e54c448afc25382ddc853013 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Neurosecretory|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.13e-06 | 181 | 180 | 7 | 092a971661b0aa06c1cdf428dbfa7339a26fb678 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.13e-06 | 181 | 180 | 7 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.13e-06 | 181 | 180 | 7 | 25915e2500430a902db37d79a749ce2990b69810 | |
| ToppCell | 3'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.46e-06 | 182 | 180 | 7 | d996ceb77c83591df4cef144ca72862f31d9777f | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.80e-06 | 183 | 180 | 7 | b4f29dd3994009bb5eb769d36d95886664e7f87d | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-05 | 186 | 180 | 7 | f07e0c0d9c80ac9d8d679950e7d0c812becb85a3 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.13e-05 | 187 | 180 | 7 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.13e-05 | 187 | 180 | 7 | 02105c82a9ba79d2f19e002188377fc3440770c2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-05 | 188 | 180 | 7 | 2ee64bc73a2251fd9f374be759b442cf4ed0d19e | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.17e-05 | 188 | 180 | 7 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.17e-05 | 188 | 180 | 7 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.17e-05 | 188 | 180 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Severe_COVID-19-Epithelial-undefined_Epi|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.21e-05 | 189 | 180 | 7 | 8cbd35320c7e7ff013ef0c0f13f8d875db1c53cd | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 190 | 180 | 7 | 68ba1934b2b3f0cec8efd229fe1db6e8be8a26b0 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-filiform|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 190 | 180 | 7 | 8a53f4d3c9aca45b5826f53f7dcdfb8bc8280acb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-05 | 190 | 180 | 7 | 3dcadabbefe0128a5f30ab51234f049ab4d870c6 | |
| ToppCell | facs-Kidney-nan-3m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 190 | 180 | 7 | 010d7d13a3c16e614c36720ef690a505b9f3f7aa | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.29e-05 | 191 | 180 | 7 | 06760c3bb40e4f66879a5f5e09c9abfce4ebbba3 | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Mac-Cycling_Myeloid-Mac|GI_small-bowel / Manually curated celltypes from each tissue | 1.29e-05 | 191 | 180 | 7 | c3944332c5226b0113f8aa9ac07837b755606c6c | |
| ToppCell | Healthy_Control-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.29e-05 | 191 | 180 | 7 | fdcdadbfc9ccae175abe4de8c7428ac4f6a67fde | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 191 | 180 | 7 | b94e66ac71e73f46b0323d424e7b8b906751d584 | |
| ToppCell | Healthy_Control-Epithelial-Epithelial-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.29e-05 | 191 | 180 | 7 | 28caedb2e448e0c7f494100d714fa7cdcf150691 | |
| ToppCell | Healthy_Control-Epithelial-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.29e-05 | 191 | 180 | 7 | 15b9386b26caaa7d15f704c4a18881e1ce918a21 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.29e-05 | 191 | 180 | 7 | 63aa671837b79d2feb7ed1e67712cc01caf72bef | |
| ToppCell | facs-GAT|facs / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 191 | 180 | 7 | 1f5d1e8c313a8dc83c06d2ee45f369b0ec507fbf | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 1.34e-05 | 192 | 180 | 7 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | P15-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.34e-05 | 192 | 180 | 7 | a476895b7b252c388d6346eacbc72f0115b1443e | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.34e-05 | 192 | 180 | 7 | 26d9207e72bbef5e0046de511e2c9ff752b726f3 | |
| ToppCell | COVID-19_Moderate-CD4+_T_activated|COVID-19_Moderate / disease group, cell group and cell class | 1.34e-05 | 192 | 180 | 7 | 7a81652406332afd03a9b3b529e9b5e6c0b54c28 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.34e-05 | 192 | 180 | 7 | b73f24d1c55dfef1eb01c26da117dbf637ea080a | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-05 | 193 | 180 | 7 | 88916d9a7d831eb52848599917c04238f8f9812b | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.38e-05 | 193 | 180 | 7 | af6ec2c2ba92aef3e41531c3c7215b3300437bd9 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.38e-05 | 193 | 180 | 7 | b25cdca3a1e381784ae48ca73c51cbb6ac62b811 | |
| Drug | Amiprilose hydrochloride [60414-06-4]; Up 200; 11.8uM; MCF7; HT_HG-U133A | SFRP4 INHBA AIRE ADGRL1 SEMA5A ZMAT4 ITGB3 USP20 TG TNFAIP3 HERC5 | 3.65e-07 | 196 | 175 | 11 | 4119_UP |
| Drug | Methoxamine hydrochloride [61-16-5]; Up 200; 16.2uM; MCF7; HT_HG-U133A | TBC1D30 ITGA10 ADGRG1 ADGRL1 RCBTB2 DDX51 ZNF592 PLXNC1 ZMIZ2 LTBP2 TNFAIP3 | 4.04e-07 | 198 | 175 | 11 | 2848_UP |
| Disease | glomerulonephritis (is_marker_for) | 4.42e-06 | 19 | 176 | 4 | DOID:2921 (is_marker_for) | |
| Disease | cryptogenic organizing pneumonia (is_marker_for) | 3.54e-05 | 2 | 176 | 2 | DOID:0050157 (is_marker_for) | |
| Disease | Mitral valve prolapse, response to surgery | 4.41e-05 | 12 | 176 | 3 | EFO_0009951, HP_0001634 | |
| Disease | colon carcinoma (is_marker_for) | 5.71e-05 | 13 | 176 | 3 | DOID:1520 (is_marker_for) | |
| Disease | skin disease (implicated_via_orthology) | 1.06e-04 | 3 | 176 | 2 | DOID:37 (implicated_via_orthology) | |
| Disease | Internal Carotid Artery Thrombosis | 2.11e-04 | 4 | 176 | 2 | C0750990 | |
| Disease | Common Carotid Artery Thrombosis | 2.11e-04 | 4 | 176 | 2 | C0750988 | |
| Disease | External Carotid Artery Thrombosis | 2.11e-04 | 4 | 176 | 2 | C0750989 | |
| Disease | Crohn's disease (biomarker_via_orthology) | 2.11e-04 | 4 | 176 | 2 | DOID:8778 (biomarker_via_orthology) | |
| Disease | Carotid Artery Thrombosis | 2.11e-04 | 4 | 176 | 2 | C0007274 | |
| Disease | Primary microcephaly | 2.96e-04 | 22 | 176 | 3 | C0431350 | |
| Disease | Pneumonia | 3.07e-04 | 54 | 176 | 4 | C0032285 | |
| Disease | Lobar Pneumonia | 3.07e-04 | 54 | 176 | 4 | C0032300 | |
| Disease | Pneumonitis | 3.07e-04 | 54 | 176 | 4 | C3714636 | |
| Disease | Experimental Lung Inflammation | 3.07e-04 | 54 | 176 | 4 | C0887898 | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 3.50e-04 | 5 | 176 | 2 | DOID:3030 (is_marker_for) | |
| Disease | polybrominated biphenyl measurement, gestational serum measurement, polybrominated diphenyl ether measurement | 3.50e-04 | 5 | 176 | 2 | EFO_0007961, EFO_0007962, EFO_0007964 | |
| Disease | interleukin-13 receptor subunit alpha-1 measurement | 3.50e-04 | 5 | 176 | 2 | EFO_0020493 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 3.74e-04 | 447 | 176 | 10 | EFO_0000694, MONDO_0100096 | |
| Disease | hepatocellular carcinoma (is_marker_for) | 4.73e-04 | 301 | 176 | 8 | DOID:684 (is_marker_for) | |
| Disease | periventricular nodular heterotopia (is_implicated_in) | 5.22e-04 | 6 | 176 | 2 | DOID:0050454 (is_implicated_in) | |
| Disease | acne (is_implicated_in) | 5.22e-04 | 6 | 176 | 2 | DOID:6543 (is_implicated_in) | |
| Disease | serum dimethylarginine measurement | 5.54e-04 | 63 | 176 | 4 | EFO_0005418 | |
| Disease | cholangiocarcinoma (is_marker_for) | 5.88e-04 | 64 | 176 | 4 | DOID:4947 (is_marker_for) | |
| Disease | Hereditary Autoinflammatory Diseases | 7.28e-04 | 7 | 176 | 2 | C0751422 | |
| Disease | acquired immunodeficiency syndrome (is_marker_for) | 7.28e-04 | 7 | 176 | 2 | DOID:635 (is_marker_for) | |
| Disease | arabinose measurement | 7.28e-04 | 7 | 176 | 2 | EFO_0021030 | |
| Disease | cholesteryl ester 16:2 measurement | 7.28e-04 | 7 | 176 | 2 | EFO_0021435 | |
| Disease | Periventricular Nodular Heterotopia | 7.28e-04 | 7 | 176 | 2 | C1868720 | |
| Disease | Manic Disorder | 8.71e-04 | 71 | 176 | 4 | C0024713 | |
| Disease | Hantavirus hemorrhagic fever with renal syndrome (is_marker_for) | 9.67e-04 | 8 | 176 | 2 | DOID:11266 (is_marker_for) | |
| Disease | thrombin generation potential measurement, thrombomodulin measurement | 9.67e-04 | 8 | 176 | 2 | EFO_0005538, EFO_0007774 | |
| Disease | visual epilepsy (implicated_via_orthology) | 1.09e-03 | 34 | 176 | 3 | DOID:11832 (implicated_via_orthology) | |
| Disease | Tinnitus | 1.12e-03 | 130 | 176 | 5 | HP_0000360 | |
| Disease | Manic | 1.24e-03 | 78 | 176 | 4 | C0338831 | |
| Disease | Mitral valve prolapse | 1.29e-03 | 36 | 176 | 3 | HP_0001634 | |
| Disease | Depression, Bipolar | 1.30e-03 | 79 | 176 | 4 | C0005587 | |
| Disease | body weight | IL13RA1 ERBB4 RTTN ADGRB3 C1QTNF9B LRP1B ADCY5 EFEMP1 SPOCK3 SCMH1 ZMIZ2 LTBP2 LTBP3 ATXN10 ADAMTS14 CDH13 GP2 | 1.50e-03 | 1261 | 176 | 17 | EFO_0004338 |
| Disease | Depressive disorder | 1.81e-03 | 289 | 176 | 7 | C0011581 | |
| Disease | polymyositis (is_marker_for) | 1.88e-03 | 11 | 176 | 2 | DOID:0080745 (is_marker_for) | |
| Disease | Autoimmune Diseases | 2.02e-03 | 42 | 176 | 3 | C0004364 | |
| Disease | age at onset, Myopia | 2.10e-03 | 150 | 176 | 5 | EFO_0004847, HP_0000545 | |
| Disease | Diabetes Mellitus, Non-Insulin-Dependent | 2.17e-03 | 221 | 176 | 6 | C0011860 | |
| Disease | stenosing tenosynovitis | 2.24e-03 | 12 | 176 | 2 | EFO_0010822 | |
| Disease | glaucoma | 2.36e-03 | 154 | 176 | 5 | MONDO_0005041 | |
| Disease | Autosomal Dominant Myotubular Myopathy | 2.64e-03 | 13 | 176 | 2 | C3661489 | |
| Disease | Centronuclear myopathy | 2.64e-03 | 13 | 176 | 2 | C0175709 | |
| Disease | X-linked centronuclear myopathy | 2.64e-03 | 13 | 176 | 2 | C0410203 | |
| Disease | Myopathy, Centronuclear, 1 | 2.64e-03 | 13 | 176 | 2 | C4551952 | |
| Disease | rostral anterior cingulate cortex volume measurement | 2.64e-03 | 13 | 176 | 2 | EFO_0010327 | |
| Disease | Congenital Structural Myopathy | 2.64e-03 | 13 | 176 | 2 | C0752282 | |
| Disease | pneumonia | 2.79e-03 | 47 | 176 | 3 | EFO_0003106 | |
| Disease | Endometrioma | 2.86e-03 | 161 | 176 | 5 | C0269102 | |
| Disease | Endometriosis | 2.86e-03 | 161 | 176 | 5 | C0014175 | |
| Disease | gastric ulcer (implicated_via_orthology) | 3.07e-03 | 14 | 176 | 2 | DOID:10808 (implicated_via_orthology) | |
| Disease | Myopathy, Centronuclear, Autosomal Dominant | 3.07e-03 | 14 | 176 | 2 | C1834558 | |
| Disease | Tubular Aggregate Myopathy | 3.07e-03 | 14 | 176 | 2 | C0410207 | |
| Disease | precuneus cortex volume measurement | 3.07e-03 | 14 | 176 | 2 | EFO_0010326 | |
| Disease | extrinsic allergic alveolitis (is_marker_for) | 3.07e-03 | 14 | 176 | 2 | DOID:841 (is_marker_for) | |
| Disease | Pancreatic Neoplasm | 3.07e-03 | 100 | 176 | 4 | C0030297 | |
| Disease | multiple sclerosis | ADAMTSL1 TG IFNGR2 RHOH IGF2R PLXNC1 RCBTB1 TNFAIP3 TNFRSF1A TOP3A | 3.13e-03 | 594 | 176 | 10 | MONDO_0005301 |
| Disease | complement factor H-related protein 4 measurement | 3.14e-03 | 49 | 176 | 3 | EFO_0600091 | |
| Disease | Malignant neoplasm of pancreas | 3.30e-03 | 102 | 176 | 4 | C0346647 | |
| Disease | 3-hydroxyanthranilic acid measurement | 3.53e-03 | 15 | 176 | 2 | EFO_0010447 | |
| Disease | Autosomal recessive primary microcephaly | 3.53e-03 | 15 | 176 | 2 | cv:C3711387 | |
| Disease | Graves' disease (is_marker_for) | 3.53e-03 | 15 | 176 | 2 | DOID:12361 (is_marker_for) | |
| Disease | Autosomal Recessive Centronuclear Myopathy | 3.53e-03 | 15 | 176 | 2 | C3645536 | |
| Disease | autoimmune disease | 3.88e-03 | 173 | 176 | 5 | EFO_0005140 | |
| Disease | lung small cell carcinoma (is_marker_for) | 4.02e-03 | 16 | 176 | 2 | DOID:5409 (is_marker_for) | |
| Disease | urate measurement, bone density | THSD4 ERBB4 ADGRB3 TG FSIP2 PLXNC1 C1QTNF9 HELZ2 PRKDC CDH13 | 4.18e-03 | 619 | 176 | 10 | EFO_0003923, EFO_0004531 |
| Disease | Mental Depression | 4.31e-03 | 254 | 176 | 6 | C0011570 | |
| Disease | Astrocytosis | 4.54e-03 | 17 | 176 | 2 | C3887640 | |
| Disease | Amyotrophic lateral sclerosis | 4.54e-03 | 17 | 176 | 2 | cv:C0002736 | |
| Disease | Gliosis | 4.54e-03 | 17 | 176 | 2 | C0017639 | |
| Disease | acute kidney failure (is_marker_for) | 4.54e-03 | 17 | 176 | 2 | DOID:3021 (is_marker_for) | |
| Disease | optic cup area measurement | 4.59e-03 | 56 | 176 | 3 | EFO_0006940 | |
| Disease | conotruncal heart malformations | 4.91e-03 | 114 | 176 | 4 | MONDO_0016581 | |
| Disease | Drug habituation | 5.06e-03 | 115 | 176 | 4 | C0013170 | |
| Disease | Drug abuse | 5.06e-03 | 115 | 176 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 5.06e-03 | 115 | 176 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 5.06e-03 | 115 | 176 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 5.06e-03 | 115 | 176 | 4 | C0013222 | |
| Disease | Drug Dependence | 5.06e-03 | 115 | 176 | 4 | C1510472 | |
| Disease | Substance Dependence | 5.06e-03 | 115 | 176 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 5.06e-03 | 115 | 176 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 5.06e-03 | 115 | 176 | 4 | C0029231 | |
| Disease | lupus nephritis (is_implicated_in) | 5.08e-03 | 18 | 176 | 2 | DOID:0080162 (is_implicated_in) | |
| Disease | Congenital Fiber Type Disproportion | 5.08e-03 | 18 | 176 | 2 | C0546264 | |
| Disease | Substance abuse problem | 5.22e-03 | 116 | 176 | 4 | C0740858 | |
| Disease | Malignant neoplasm of breast | ERBB4 GFRAL HK3 TFPI2 OBSCN ARFGEF2 GRIK3 PKDREJ EEF2 EFEMP1 PER3 SYNE2 LGR6 ZNF541 | 5.22e-03 | 1074 | 176 | 14 | C0006142 |
| Disease | congenital heart disease | 5.31e-03 | 59 | 176 | 3 | EFO_0005207 | |
| Disease | prion disease | 5.66e-03 | 19 | 176 | 2 | EFO_0004720 | |
| Disease | acetone measurement | 5.66e-03 | 19 | 176 | 2 | EFO_0010989 | |
| Disease | hydrocephalus (implicated_via_orthology) | 5.66e-03 | 19 | 176 | 2 | DOID:10908 (implicated_via_orthology) | |
| Disease | disease progression measurement | 5.83e-03 | 61 | 176 | 3 | EFO_0008336 | |
| Disease | open-angle glaucoma | 5.88e-03 | 191 | 176 | 5 | EFO_0004190 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QTCNKVRCVVPQTTV | 106 | Q8N9N5 | |
| ISDVQCGRIQCENVT | 546 | Q9UKF5 | |
| TENHCQTLTRTVCAE | 201 | Q15303 | |
| QTLTRTVCAEQCDGR | 206 | Q15303 | |
| CQCTSVGAQNTVICS | 46 | P16422 | |
| IQTRDTNFGTNCICR | 106 | P41223 | |
| VRSSFANQGEICLCT | 276 | Q9H2A2 | |
| ANQGEICLCTSRIFV | 281 | Q9H2A2 | |
| CFASAVECLQQISTT | 1551 | Q96Q42 | |
| LVNETQDIVTCQCTH | 551 | Q5T601 | |
| TEGCLTQELQTTQVC | 226 | O60242 | |
| TCGQGSQVRTRTCVS | 306 | O60242 | |
| ETTNIFSNCGCVRAE | 346 | Q9UBB4 | |
| IMSQRCNNRTQCVVV | 91 | O94910 | |
| CNNRTQCVVVAGSDA | 96 | O94910 | |
| QTLTRICADAQCVVD | 501 | Q9Y6D5 | |
| GQCCTAASRVFVEEQ | 311 | P47895 | |
| QQCQGDTVISECLQR | 66 | Q96P50 | |
| VNNTFQTCVEVGVRV | 251 | Q8WYK0 | |
| RCNNRTQCIVVTGSD | 96 | O95490 | |
| SNVLIFSCTNIVGVC | 381 | O95622 | |
| SQVATTGTAVCINFC | 546 | Q32M45 | |
| NITDLRVQVCSCRNS | 671 | P55290 | |
| ICQRTTQTVECTQTG | 1161 | Q8IZT6 | |
| VSRIVEAGCVCNDAV | 401 | P98194 | |
| SATCGEGIQQRQVVC | 981 | Q8WXS8 | |
| VTCGEGTQRRNVLCT | 956 | Q9UKP4 | |
| RCSSCLQATVQEVQP | 336 | O43918 | |
| RIACEQCQESGASLV | 241 | P08476 | |
| GIQRVVCGVSEQTTC | 16 | Q02833 | |
| VCGVSEQTTCQEVVI | 21 | Q02833 | |
| QRIVCGVTEVTTCQE | 11 | Q8NHQ8 | |
| RVAALHSVCVNQIVC | 226 | Q8NDN9 | |
| TTVNDEIFVLGTNCC | 61 | O95199 | |
| LISSVCCVFAQTDEN | 11 | P05556 | |
| FIATSICCQQLRQEG | 506 | P54829 | |
| QCVNVSVVSEEVCSK | 166 | Q9Y5K2 | |
| TVCLETGSQNVQLCT | 331 | Q96EP9 | |
| NVTVTRCEGACISAA | 2366 | Q6W4X9 | |
| SFNIITQQVDARCSC | 2381 | Q6W4X9 | |
| QSCSRITDEGVVQIC | 216 | Q9UKC9 | |
| TNGSALCTRCIQINT | 1061 | Q13045 | |
| VGSQVSCRTCQEQRL | 11 | Q3MHD2 | |
| SCRTCQEQRLQGEVV | 16 | Q3MHD2 | |
| RIFVCNSNGSVCVTL | 306 | Q9NZR2 | |
| TCVKTSQTAVCIEAN | 256 | Q4G0Z9 | |
| SQTAVCIEANSITFC | 261 | Q4G0Z9 | |
| QQIIVSLTESCRSCS | 126 | Q92831 | |
| TCVEVIVTNENTSCT | 426 | Q9H3C7 | |
| TLAAVQCSVSVSCVR | 661 | Q9HBX8 | |
| VTVSNRLVSSSCCIV | 351 | Q58FF8 | |
| CSNRSKDVLVVNCTA | 3806 | Q15751 | |
| CSVAACNTEAQGVQE | 626 | Q14164 | |
| QVNLIFCDEVSVSAC | 5961 | Q5CZC0 | |
| VTCGVGTQVRIVRCQ | 536 | Q8N6G6 | |
| CSVQEDINSLCLTVV | 96 | P54868 | |
| TVTQEIDIQACVTCE | 1166 | P56645 | |
| VCRNISVNVLDCDTI | 1216 | O60486 | |
| VAVCSCLTSQIRDVG | 596 | Q9P2G9 | |
| EQCQPSCSRSQVRSE | 471 | P55259 | |
| QQVLVCSQEGSSRRC | 256 | Q8IW45 | |
| SSCEGLSCQQTRVLQ | 361 | Q8WY64 | |
| CSVVGSLNVNRCNQT | 206 | Q9H1U4 | |
| VTCSEVSEGNITVTC | 211 | Q29980 | |
| QTIRVGCNTCTCDSR | 876 | P98088 | |
| VVQCSREEGLVCRNQ | 2181 | P98088 | |
| QVVQCSREEGLVCRN | 3286 | P98088 | |
| QVVQCSREEGLVCRN | 4691 | P98088 | |
| LCSQDCQVVRGVDSD | 4811 | P98088 | |
| VRATVAQFNTVTGCV | 291 | Q3MIN7 | |
| LEVCQAVSQRAAQLC | 826 | P52790 | |
| CHSGSSQICEQVIIQ | 231 | Q8WVV4 | |
| SICVVQDGRLEVCIQ | 181 | Q6ZV29 | |
| NERICLQVGSQCSTN | 91 | P78552 | |
| VCTCSTVEVQAVLSA | 591 | Q6VY07 | |
| QVQSRTKIEECVVCS | 856 | Q86YT6 | |
| TVDASENVQCCVIFS | 616 | Q9UII4 | |
| TLTISQCCLEDVGQV | 476 | Q5VST9 | |
| VGCTRRLVVQQACQA | 1401 | Q5VST9 | |
| SCVCGQERTSATLTV | 3871 | Q5VST9 | |
| SATFRVCGENVTCVE | 1426 | Q460N5 | |
| EICTGNINSQDTCRQ | 11 | P0C862 | |
| TQQTIASCLCTNLVI | 426 | O75419 | |
| VLAACQQQSTVECFA | 81 | O95760 | |
| VDFATIQCGQCLVET | 1706 | Q4G0P3 | |
| ATQTQIDAVCCRRCV | 341 | Q86XA9 | |
| RQCQEGVVTESGVRC | 131 | Q8N8U9 | |
| DVETCSNQQIRQTCV | 171 | Q86V35 | |
| DILGTVLQVQCTCRT | 281 | Q6UXV0 | |
| VLQVQCTCRTITQSE | 286 | Q6UXV0 | |
| CCRVNGEVVQSSNTN | 236 | Q6P2I3 | |
| TSVCVNVQSCTKERV | 231 | Q0VF96 | |
| QRRQAQAVTAASTCC | 406 | Q8N8A6 | |
| TCLESALVGVCNIVQ | 86 | Q96SY0 | |
| ISNCAVSTNIDICFQ | 286 | P51686 | |
| EICTGNINSQDTCRQ | 11 | B2RNN3 | |
| CETVRRETQTSCFCN | 366 | Q9Y653 | |
| QRLATQAVVLCSCQG | 206 | A2IDD5 | |
| VLGRNTTQAECCCTQ | 1426 | Q14767 | |
| QVTETDECRLNQNIC | 571 | Q9NS15 | |
| SVLATNVTQQECCCS | 931 | Q9NS15 | |
| GCQLVCCQSSNVSVI | 206 | Q9BY19 | |
| QFNSVANCVITTCLG | 436 | Q12967 | |
| SIGVNCTQITATECD | 81 | P38484 | |
| QEAVCLTAALCFQVT | 671 | O75578 | |
| CTTRGVSSCQQCLAV | 31 | P05106 | |
| VSSVEECQKRCTNNI | 131 | P03952 | |
| CSQTQENTECTVCLF | 976 | Q86Z14 | |
| LVVVDCVSGVCVQTE | 126 | P13639 | |
| CVSGVCVQTETVLRQ | 131 | P13639 | |
| NCDINSIVTQNGEVC | 31 | Q5T6L9 | |
| TGSNCQCNVEVVRAL | 676 | Q8WXE1 | |
| SCTNAVQSICNALEV | 116 | Q13003 | |
| EQRCICVVSHGAQVS | 826 | Q9BYK8 | |
| CVCNGVAVRSNQDLI | 606 | P21817 | |
| CQVALSCLVSRDGNV | 151 | Q9BZW8 | |
| RICEIQAVDCTTISS | 521 | Q9Y597 | |
| NVTETQVCLSIEACT | 146 | Q68DL7 | |
| IVRNICTTAGESNCF | 1171 | A6NMZ7 | |
| CTTAGESNCFVDVVV | 1176 | A6NMZ7 | |
| RLCEGVEAVNVCVSS | 421 | P78385 | |
| VSSSEQLQCCQTEII | 296 | O76013 | |
| RSCVNGTLVCSTTQL | 511 | Q9H1H9 | |
| VVRSRTCQDINECET | 326 | Q12805 | |
| CEQATECSVRNGSSI | 1646 | P11717 | |
| CSIADATLIQTCVQE | 1646 | Q86VV8 | |
| DISVEICNVCSCVSV | 21 | Q8IW52 | |
| SCTGAVRCQSQVAEA | 26 | P49590 | |
| VRCQSQVAEAVLTSQ | 31 | P49590 | |
| FVCLENCSLQERTVT | 156 | Q9UQK1 | |
| TFQSCVITKECQVSE | 351 | Q9UPZ6 | |
| QVCLEHTQAAAVCRS | 4611 | Q8WXH0 | |
| VQRCQSGTVRTNCLD | 371 | O43426 | |
| QTVVLCVGCSTVLCQ | 51 | Q71UM5 | |
| CSALSNRGVQQVFEC | 151 | Q15669 | |
| SSVSCQINACVIQRV | 206 | Q9NTG1 | |
| TNICTACEPIQIVNV | 401 | O75343 | |
| QKDCVIVTCVRANSI | 2381 | Q7Z333 | |
| VIEIQASDSQCQAFC | 581 | Q5VXU9 | |
| NVIENCICANMSVSR | 176 | Q8NH54 | |
| QRVCLERVQCSTASG | 216 | B7ZBB8 | |
| TLENCVLQCETTGVT | 456 | Q8NEM2 | |
| SVVIQQLCSVCVFVV | 56 | Q92535 | |
| CRQSVNVESILGNSC | 236 | Q9NWQ8 | |
| SVTVQEGLCVSVLCS | 31 | Q96PQ1 | |
| CEKCSTSIANQAVRI | 286 | Q96JY6 | |
| SVVLQQAVQACIDCA | 391 | Q96GD3 | |
| SECEASGVQVRARQC | 906 | Q13591 | |
| TLQVASRNLCCVDEV | 26 | Q5TBC7 | |
| VALVGAQCTNCVQDD | 96 | O15551 | |
| LVAITGAQCTTCVED | 96 | O95484 | |
| NACATQAIVSVLLNC | 86 | Q9Y5K5 | |
| EIINCSNCESVGTNA | 1176 | Q15468 | |
| SQFLVDGVCTVANCV | 491 | Q8N0X7 | |
| EVTVQRNCCLTLCNF | 451 | Q7Z7L7 | |
| CEVRQEAGTCQFSLV | 91 | Q1L6U9 | |
| CQACLQDVTRTFNGI | 521 | P21580 | |
| IITEDNKVNGVTCCT | 936 | Q6ZVD8 | |
| AGQANVCDVVTSTVC | 256 | Q9H2B4 | |
| VQRSGCNEVTTVVDV | 206 | Q6FHJ7 | |
| CSLVIDSRVNICIQQ | 156 | Q9BX26 | |
| QRTTEETEGLTCQVC | 731 | Q92610 | |
| CNECGKTFRQTSQVI | 276 | Q6AZW8 | |
| SQCGTVIDVNIDCAV | 161 | Q9C0C9 | |
| FQGTLTNETRCLTCE | 176 | O75317 | |
| IASCVNCLTVLAARN | 611 | Q5SRE5 | |
| LVQAQEVCLSQCQES | 46 | Q5T870 | |
| VRCLGTETRLTQCNV | 501 | Q4G0T1 | |
| LSDSVCAVCGQQIFV | 221 | Q9H920 | |
| VQRNCDIVTACLQAV | 196 | Q9Y2I9 | |
| TTRNTVCQCEEGTFR | 131 | O14763 | |
| SVVSQLIRCCNVSST | 2231 | O00507 | |
| CRQSSGENCDVVVNT | 271 | P01833 | |
| DICQRGTSLTIQCQV | 26 | A0A5B7 | |
| LCTVQSVNCRDIEGR | 511 | Q9H2K2 | |
| LVQCLTCDRVSTTVE | 456 | Q9Y2K6 | |
| VTCNCGQEAVLLTVR | 811 | Q13472 | |
| CIAQDSQTAVCISHR | 101 | Q9BQ16 | |
| CRSRSQGCSEQVLTV | 3286 | P78527 | |
| CQPGRNTIQITVTAC | 516 | Q8NF64 | |
| AITRGTQQLCFCVLT | 486 | Q92536 | |
| RETVFVCASCNQTLS | 396 | Q5T4F4 | |
| LTGNRVVTTCADCNL | 506 | Q9H967 | |
| FTNSEVTCQCLEVVG | 196 | O43592 | |
| ETQACTREQNRICTC | 106 | P20333 | |
| GTQVNVTCIVNVCSS | 376 | P20333 | |
| CRLQVSVDDQCEGST | 96 | P48307 | |
| IECGSGTQQREVICV | 866 | Q6ZMP0 | |
| NTAVCVCNESVRTVI | 261 | Q5T5U3 | |
| VCNNSSVQVGCLTRE | 1346 | P01266 | |
| QVEISSCTVDRDTVC | 111 | P19438 | |
| NIRINGCAIQCRVTT | 366 | P11498 | |
| LLSAQVCCVRGIQVE | 11 | A0A0B4J277 | |
| CKVCSAQLISESQRV | 16 | Q9H898 | |
| QTVVLCVGCSTVLCQ | 51 | P42677 | |
| SVQCLTCDRVSVTLE | 486 | Q8TEY7 | |
| TCCDVSSNNRLVVTG | 546 | Q9H808 | |
| GQQQVCVSQATVGTC | 991 | Q9ULM3 | |
| ETQDRVTELCNVACS | 1096 | Q9H0D2 | |
| TATCRAGSQERVCFQ | 61 | Q8N8K9 |